KU 210 (Montelukast sodium 10 mg (base))
Pill imprint KU 210 has been identified as Montelukast sodium 10 mg (base).
Montelukast is used in the treatment of bronchospasm prophylaxis; allergic rhinitis; asthma, maintenance; copd; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
- 10 mg (base)
- Prescription only
hydroxypropyl cellulose (type h)
sodium stearyl fumarate
More about montelukast
- Other brands: Singulair
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.